1,4-Naphthoquinone improves depressive-like behaviors by modulating neuronal factors and neuroinflammatory mediators
Pharmacology Biochemistry and Behavior · 2026
DOI: 10.1016/j.pbb.2025.174133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2026. Verfasst von Joo Hye Sim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Medicine, College of Korean Medicine, Daejeon University, Daejeon, 34520, Republic of Korea. Hauptthemen laut MEDLINE: Naphthoquinones, Depression, Neurons, Antidepressive Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Korea Ministry of Science and ICT.
Abstract (Originalsprache)
Depression is a chronic mental disorder characterized by alternations in emotions, thoughts, physical condition, and behavior. Using the natural product database Compound Combination-Oriented Natural Product Database with Unified Terminology (COCONUT) and the bioinformatics tool CODA (Context-Oriented Directed Associations), we screened and identified 1,4-naphthoquinone (1,4-NQ) as a promising candidate for depression treatment. Oral administration of 1,4-NQ attenuated the depressive-like behaviors in the open field test (OFT), elevated plus maze test (EPM) and forced swim test (FST) in a chronic restraint stress (CRS)-induced depressive-like mouse model. Real-time PCR analysis demonstrated that 1,4-NQ increased the mRNA levels of 5-HT1A and BDNF in the hippocampus of mouse brains. The expression level of glucocorticoid receptor (GR) in the hippocampus was increased by 1,4-NQ treatment in both CRS- and corticosterone-induced depression mouse models. We confirmed that 1,4-NQ has anti-neuroinflammatory efficacy by suppressing the levels of IL-6, TNF-α and IL-1β in LPS-stimulated BV2 microglial cell line. The western blot and real-time PCR analysis demonstrated that 1,4-NQ increased the level of GR in both the U-138 MG glial cell line and the SH-SY5Y neuronal cell line. In conclusion, 1,4-NQ is supposed to have anti-depressive efficacy by alleviating depressive-like behaviors through modulation of neuroinflammatory mediators and GR expression in the nervous system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Medicine, College of Korean Medicine, Daejeon University, Daejeon, 34520, Republic of Korea.
- Department of Bio and Brain Engineering, KAIST, Yuseong-gu, Daejeon, 34141, Republic of Korea.
- Bio-Synergy Research Center, Yuseong-gu, Daejeon, 34141, Republic of Korea.
- Laboratory of Molecular Medicine, College of Korean Medicine, Daejeon University, Daejeon, 34520, Republic of Korea. Electronic address: c27022@dju.ac.kr.
Förderung
- National Research Foundation of Korea
- Korea Ministry of Science and ICT
Zitieren
APA
Sim, J. H., Choi, H. J., Kwon, O., Kim, T., Lee, D., & Choi, J. J. (2026). 1,4-Naphthoquinone improves depressive-like behaviors by modulating neuronal factors and neuroinflammatory mediators. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2025.174133
Vancouver
Sim JH, Choi HJ, Kwon O, Kim T, Lee D, Choi JJ. 1,4-Naphthoquinone improves depressive-like behaviors by modulating neuronal factors and neuroinflammatory mediators. Pharmacology Biochemistry and Behavior. 2026. doi:10.1016/j.pbb.2025.174133
BibTeX
@article{Sim2026,
author = {Sim, Joo Hye and Choi, Hye Jin and Kwon, Ohhyeon and Kim, Taeyeon and Lee, Doheon and Choi, Jeong June},
title = {1,4-Naphthoquinone improves depressive-like behaviors by modulating neuronal factors and neuroinflammatory mediators},
journal = {Pharmacology Biochemistry and Behavior},
year = {2026},
doi = {10.1016/j.pbb.2025.174133}
}
EUVIMED